Kimmel, G., Chima, M., Kim, H.J., Bares, J., Yaroshinsky, A., Singer, G., Kim, S.J., Bagel, J. and Lebwohl, M. 2021. Brodalumab in the treatment of moderate-to-severe psoriasis in patients refractory to anti-interleukin-17A therapies: Evaluation of secondary endpoints. SKIN The Journal of Cutaneous Medicine. 5, 5 (Sep. 2021), 524–529. DOI:https://doi.org/10.25251/skin.5.5.10.